XML 26 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combination and Asset Acquisitions Pro Forma Information (Details) (Gentium [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Gentium [Member]
       
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]        
Revenues $ 306,584 $ 247,478 $ 848,036 $ 674,491
Net income (loss) attributable to Jazz Pharmaceuticals plc $ 26,317 $ 61,330 $ (1,887) $ 98,418
Net income (loss) per ordinary share - basic (in dollars per share) $ 0.44 $ 1.05 $ (0.03) $ 1.68
Net income (loss) per ordinary share - diluted (in dollars per share) $ 0.42 $ 1.00 $ (0.03) $ 1.60